Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

NCT05956834 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05956834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05956834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 28, 2023
Completion date
December 30, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cbd, corticobasal degeneration, frontotemporal dementia, frontotemporal lobar degeneration, ftd, progressive supranuclear palsy, psp